CHMP4B |
CHMP4B, C20orf178, SHAX1: Charged multivesicular body protein 4b |
VPS24 |
VPS24, CHMP3, CGI-149, NEDF: Charged multivesicular body protein 3 |
146.000 |
Evidence |
O
|
RANBP3 |
RANBP3: Ran-binding protein 3 |
CHC1 |
RCC1: RCC1-I (Fragment) |
143.000 |
Evidence |
|
SYK |
SYK: Tyrosine-protein kinase SYK |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
143.000 |
Evidence |
|
GABARAP |
GABARAP, FLC3B, HT004: Gamma-aminobutyric acid receptor-associated protein |
ATG3 |
ATG3, APG3, APG3L: Autophagy-related protein 3 |
142.000 |
Evidence |
|
KIT |
KIT: Mast/stem cell growth factor receptor precursor |
GRB10 |
IPI00012752 |
141.000 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
GRB10 |
IPI00012752 |
141.000 |
Evidence |
|
INSR |
INSR: Insulin receptor precursor |
GRB10 |
IPI00012752 |
141.000 |
Evidence |
|
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
GRB10 |
IPI00012752 |
141.000 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
GRB10 |
IPI00012752 |
141.000 |
Evidence |
|
EIF3S2 |
EIF3S2, TRIP1: Eukaryotic translation initiation factor 3 subunit 2 |
EIF3S10 |
EIF3S10, KIAA0139: Eukaryotic translation initiation factor 3 subunit 10 |
140.000 |
Evidence |
O
|
SYK |
SYK: Tyrosine-protein kinase SYK |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
139.000 |
Evidence |
|
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
139.000 |
Evidence |
|
SYK |
SYK: Tyrosine-protein kinase SYK |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
139.000 |
Evidence |
|
F7 |
F7: Coagulation factor VII precursor |
F5 |
F5: Coagulation factor V precursor |
139.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
137.000 |
Evidence |
|
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
137.000 |
Evidence |
O
|
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
137.000 |
Evidence |
|
PROS1 |
PROS1, PROS: Vitamin K-dependent protein S precursor |
F5 |
F5: Coagulation factor V precursor |
136.000 |
Evidence |
|
CDC37 |
CDC37: Hsp90 co-chaperone Cdc37 |
HSP90AA1 |
Hsp89-alpha-delta-N |
136.000 |
Evidence |
O
|
PLD2 |
PLD2: Phospholipase D2 |
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
136.000 |
Evidence |
|
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
BMX |
IPI00514142 |
135.000 |
Evidence |
|
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
MAPK8 |
MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 |
135.000 |
Evidence |
|
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
JAK1 |
|
135.000 |
Evidence |
|
INSR |
INSR: Insulin receptor precursor |
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
135.000 |
Evidence |
|
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
135.000 |
Evidence |
|